Blood Lipids and the Risk of Colorectal Cancer: Mendelian Randomization Analyses in the Japanese Consortium of Genetic Epidemiology Studies
Masao Iwagami(University of Tsukuba), Motoki Iwasaki, Kenji Takeuchi(University of Fukui), Akira Narita(Tohoku University), Kiyonori Kuriki(University of Shizuoka), Atsushi Hozawa(Tohoku University), Kengo Kinoshita(Tohoku University), Sadao Suzuki(Nagoya City University), Kenji Wakai(Japanese Society for Dialysis Therapy), Sho Nakamura(Kanagawa Prefectural Hospital Organization), Atsushi Shimizu(Keio University), Yohko Nakamura(Chiba Cancer Center), Hidemi Ito(Aichi Cancer Center), Masahiro Nakatochi(Nagoya University), Shoichiro Tsugane(International University of Health and Welfare), Taiki Yamaji, Akiko Hanyuda(National Center for Global Health and Medicine), Yuriko N. Koyanagi(Aichi Cancer Center), Yumiko Kasugai(Aichi Cancer Center), Ryoko Katagiri(Chiba University), Atsushi Goto, Keitaro Matsuo(Aichi Cancer Center), Shiori Nakano(Yokohama City University), Kozo Tanno(Iwate Medical University), Norie Sawada(National Cancer Center), Issei Imoto(Tokushima University), Yoichi Sutoh(Hokkaido University), Asahi Hishida(Nagoya City University), Isao Oze(Aichi Cancer Center), Makoto Sasaki(Iwate Medical University), Yukihide Momozawa(RIKEN Center for Integrative Medical Sciences), Masayuki Yamamoto(Tohoku University), Midori Suzuki(Aichi Cancer Center)
Cited by 14
Related Papers
A cross-population atlas of genetic associations for 220 human phenotypes
|Nature Genetics|2021|2.4k
Nrf2 suppresses macrophage inflammatory response by blocking proinflammatory cytokine transcription
|Nature Communications|2016|1.8k
Metagenomic and metabolomic analyses reveal distinct stage-specific phenotypes of the gut microbiota in colorectal cancer
|Nature Medicine|2019|1.5k
Nrf2 Redirects Glucose and Glutamine into Anabolic Pathways in Metabolic Reprogramming
|Cancer Cell|2012|1.4k